Legal & General Group
CNTB

Legal & General Group’s Connect Biopharma Holdings CNTB Stock Holding History

Legal & General Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.75K Buy
+2,415
New +$5.86K ﹤0.01% 3367

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Legal & General Group's CNTB Position: Q2 2026 in Review

Legal & General Group opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 2,415 shares worth $5.75K. The stake represents ﹤0.01% of the portfolio and ranks #3367 among its holdings.

56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Legal & General Group held 2,415 shares of Connect Biopharma Holdings worth $5.75K as of Q2 2026.
  • Connect Biopharma Holdings was a new Legal & General Group position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3367 holding.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.